BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 2556265)

  • 1. The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines.
    Macchi M; Bornert JM; Davidson I; Kanno M; Rosales R; Vigneron M; Xiao JH; Fromental C; Chambon P
    EMBO J; 1989 Dec; 8(13):4215-27. PubMed ID: 2556265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties.
    Kanno M; Fromental C; Staub A; Ruffenach F; Davidson I; Chambon P
    EMBO J; 1989 Dec; 8(13):4205-14. PubMed ID: 2556264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain B1 of the SV40 enhancer.
    Xiao JH; Davidson I; Ferrandon D; Rosales R; Vigneron M; Macchi M; Ruffenach F; Chambon P
    EMBO J; 1987 Oct; 6(10):3005-13. PubMed ID: 2826126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General repression of enhanson activity by the adenovirus-2 E1A proteins.
    Rochette-Egly C; Fromental C; Chambon P
    Genes Dev; 1990 Jan; 4(1):137-50. PubMed ID: 2155159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers.
    Rosales R; Vigneron M; Macchi M; Davidson I; Xiao JH; Chambon P
    EMBO J; 1987 Oct; 6(10):3015-25. PubMed ID: 2826127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts.
    Davidson I; Fromental C; Augereau P; Wildeman A; Zenke M; Chambon P
    Nature; 1986 Oct 9-15; 323(6088):544-8. PubMed ID: 3020434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.
    Baldwin AS; Sharp PA
    Proc Natl Acad Sci U S A; 1988 Feb; 85(3):723-7. PubMed ID: 3422454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif.
    Phares W; Franza BR; Herr W
    J Virol; 1992 Dec; 66(12):7490-8. PubMed ID: 1331533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity and interleukin 1 responsiveness of SV40 enhancer motifs in a rodent immature T cell line.
    Espel E; Fromental C; Reichenbach P; Nabholz M
    EMBO J; 1990 Mar; 9(3):929-37. PubMed ID: 2155785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences.
    Urban MB; Baeuerle PA
    New Biol; 1991 Mar; 3(3):279-88. PubMed ID: 1878350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic interactions between overlapping binding sites for the serum response factor and ELK-1 proteins mediate both basal enhancement and phorbol ester responsiveness of primate cytomegalovirus major immediate-early promoters in monocyte and T-lymphocyte cell types.
    Chan YJ; Chiou CJ; Huang Q; Hayward GS
    J Virol; 1996 Dec; 70(12):8590-605. PubMed ID: 8970984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mouse immunoglobulin heavy-chain enhancer: effect on transcription in vitro and binding of proteins present in HeLa and lymphoid B cell extracts.
    Augereau P; Chambon P
    EMBO J; 1986 Aug; 5(8):1791-7. PubMed ID: 3019664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro binding of several cell-specific and ubiquitous nuclear proteins to the GT-I motif of the SV40 enhancer.
    Xiao JH; Davidson I; Macchi M; Rosales R; Vigneron M; Staub A; Chambon P
    Genes Dev; 1987 Oct; 1(8):794-807. PubMed ID: 2828172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-enriched HNF-3 alpha and ubiquitous factors interact with the human transferrin gene enhancer.
    Augé-Gouillou C; Petropoulos I; Zakin MM
    FEBS Lett; 1993 May; 323(1-2):4-10. PubMed ID: 8495744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor beta (TNF-beta) induces binding of the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter.
    Messer G; Weiss EH; Baeuerle PA
    Cytokine; 1990 Nov; 2(6):389-97. PubMed ID: 2104232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A purine-rich DNA sequence motif present in SV40 and lymphotropic papovavirus binds a lymphoid-specific factor and contributes to enhancer activity in lymphoid cells.
    Petterson M; Schaffner W
    Genes Dev; 1987 Nov; 1(9):962-72. PubMed ID: 2828177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
    Mondal D; Alam J; Prakash O
    J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiprotein complex consisting of the cellular coactivator p300, AP-1/ATF, as well as NF-kappaB is responsible for the activation of the mouse major histocompatibility class I (H-2K(b)) enhancer A.
    Brockmann D; Pützer BM; Lipinski KS; Schmücker U; Esche H
    Gene Expr; 1999; 8(1):1-18. PubMed ID: 10543727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor.
    Hansen SK; Guerrini L; Blasi F
    J Biol Chem; 1994 Sep; 269(35):22230-7. PubMed ID: 8071349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.
    Phares W; Herr W
    J Virol; 1991 May; 65(5):2200-10. PubMed ID: 1850006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.